期刊文献+

非小细胞肺癌淋巴结转移与肿瘤原发灶最大径及^(18)F-FDG PET/CT代谢参数的相关性 被引量:16

Correlation Between Lymph Node Metastasis with Maximum Diameter of Primary Lesion and Metabolic Parameters of ^(18)F-FDG PET/CT in Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的探讨非小细胞肺癌(NSCLC)原发灶最大径和代谢参数与淋巴结转移的关系。资料与方法回顾性分析2015年12月—2018年1月于南京中医药大学沭阳附属医院行^(18)F-脱氧葡萄糖(^(18)F-FDG)PET/CT检查且初诊为NSCLC的87例患者肿瘤原发灶的最大径、最大标准化摄取值(SUVmax)、平均标准化摄取值(SUVmean)、代谢体积(MTV)和病灶糖酵解总量(TLG),根据肿瘤原发灶最大径分为结节组(28例)和肿块组(59例),分析各参数与淋巴结转移的相关性;根据原发灶最大径和SUVmax的界值将患者分为低危组(21例)、中危组(33例)和高危组(33例),分析各组淋巴结转移的差异。结果 87例NSCLC患者原发灶代谢参数SUVmax、SUVmean、MTV、TLG分别为9.13±5.12、5.26±2.88、12.56(4.98,29.41)cm3、76.53(16.20,211.20)g。结节组和肿块组肿瘤原发灶最大径与代谢参数SUVmax、SUVmean、MTV、TLG差异均有统计学意义(P<0.001),肿瘤原发灶最大径与SUVmax、SUVmean、MTV、TLG呈正相关(r=0.640、0.636、0.749、0.789,P均<0.05)。原发灶的最大径与肿瘤N分期呈正相关(r=0.368,P<0.05);SUVmax、SUVmean与肿瘤N分期呈正相关(r=0.335、0.331,P<0.05)。低危组、中危组、高危组淋巴结转移发生率分别为33.3%(7/21)、72.7%(24/33)和87.9%(29/33),差异有统计学意义(x^2=18.19,P<0.05)。结论 NSCLC肿瘤原发灶SUVmax和最大径与淋巴结转移有关,SUVmax联合肿瘤原发灶最大径可以预测肿瘤淋巴结转移风险。 Purpose To investigate the correlation between the maximum diameter of primary lesion and metabolic parameters with lymph node metastasis in non-small cell lung cancer (NSCLC). Materials and Methods The maximum diameter o f primary lesion, maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of 87 NSCLC patients who received 18F-fluorodeoxyglucose (18F-FDG) PET/CT examination in Shuyang Affiliated Hospital of Nanjing University o f Chinese Medicine from December 2015 to January 2018 were retrospectively analyzed. The patients were assigned into nodule group (28 cases) and mass group (59 cases) according to the maximum diameter of primary lesion, and the correlation of each parameter and lymph node metastasis was analyzed;the patients were further assigned into low-risk group (21 cases), moderate-risk group (33 cases), and high-risk group (33 cases) based on the maximum diameter of primary lesion and SUVmax, and the difference in lymph node metastasis among the three groups were analyzed. Results SUVmax, SUVmean, MTV and TLG, the metabolic parameters o f primary lesion, were respectively 9.13±5.12, 5.26±2.88, 12.56 (4.98, 29.41) cm3 and 76.53 (16.20, 211.20) g. The maximum diameter of primary lesion was in positive correlation with SUVmax, SUVmean, MTV and TLG (r=0.640, 0.636, 0.749 and 0.789, respectively, all P<0.001), with statistically significant differences between nodule group and mass group (all P<0.05). The maximum diameter of primary lesion, SUVmax and SUVmean were in moderately positive correlation with the N stage of primary lesion (r=0.368, 0.335 and 0.331, respectively, all P<0.05). The incidence of lymph node metastasis was respectively 33.3%(7/21), 72.7%(24/33) and 87.9%(29/33) in low-risk group, moderate-risk group and high-risk group, with statistical significance (χ^2=18.19, P<0.05). Conclusion The maximum diameter of primary lesion and SUVmax are related to lymph node metastasis. The risk o f lymph node metastasis can be predicted by combining SUVmax and the maximum diameter of primary lesion in NSCLC.
作者 周锦 汤泊 张银 徐阳 胡春峰 ZHOU Jin;TANG Bo;ZHANG Yin;XU Yang;HU Chunfeng(Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, China)
出处 《中国医学影像学杂志》 CSCD 北大核心 2019年第3期188-192,共5页 Chinese Journal of Medical Imaging
基金 宿迁市指导性科技计划项目(Z2018019)
关键词 非小细胞肺 正电子发射断层显像术 体层摄影术 X线计算机 氟脱氧葡萄糖F18 淋巴转移 Carcinoma, non-small-cell lung Positron-emission tomography Tomography, X-ray computed Fluorodeoxyglucose FI 8 Lymphatic metastasis
  • 相关文献

参考文献5

二级参考文献52

  • 1党亚萍,刘刚,王红,李苗.PET/CT对肺内结节诊断及治疗的临床价值[J].中华肿瘤杂志,2004,26(11):685-687. 被引量:21
  • 2潘铁成,郑智,李军,汤应雄,潘友民,魏翔,陈涛,张霓.肺鳞癌、腺癌肿瘤大小与淋巴结转移关系的临床研究[J].中国肺癌杂志,2006,9(3):267-269. 被引量:13
  • 3穆殿斌,王绍平,杨文锋,付政,陈绪霞,孙晓蓉,于金明.食管癌组织中葡萄糖转运蛋白1表达和Ki-67抗原标记指数与PET/CT显示的^18F-FDG摄取水平相关[J].中华肿瘤杂志,2007,29(1):30-33. 被引量:22
  • 4Pozo-Rodriguez F, Martin de Nicolas JL, Sanchez-Nistal MA, el al. Accuracy of helical computed tomography and [ 18F ] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non- small-cell lung cancer. J Clin Oncol, 2005, 23 : 8348-8356.
  • 5Aquino SL, Asmuth JC, Alpert NM, et al. Improved radiologic staging of lung cancer with 2-[ 18F]-fluoro-2-deoxy-D-glucosepositron emission tomography and computed tomography registration. J Comput Assist Tomogr, 2003,27:479-484.
  • 6Shim SS, Lee KS, Kim BT, ct al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology, 2005, 236 : 1011-1019.
  • 7Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol, 2007, 2:706-714.
  • 8Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med, 2003, 348:2500-2507.
  • 9Yuan S, Yu Y, Chao KS, et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med, 2006, 47 : 1255- 1259.
  • 10Turkmen C, Sonmezoglu K, Toker A, et al. The additional value of FDG PET imaging for distinguishing NO or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med, 2007, 52:607-612.

共引文献32

同被引文献130

引证文献16

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部